Navigation auf uzh.ch

Small RNAs (former CRPP/KFSP)

Publish and Cherish

The purpose of the "Publish and Cherish" Zoom Seminar Series is the discussion of radical and innovative ideas with the actual makers of biomedical research.
We are interested in hearing from first authors of scientific biomedical publications to learn about their area of research, but also about how their projects developed over time:

  • How did they come up with the project idea and to what extent did they modify the aims of the study?
  • Which technical issues and setbacks did they encounter and how did they resolve or circumvent them?
  • How did the publishing process go and how did they respond to the reviewers’ comments?

In addition to the exciting findings which they published, authors are encouraged to include failed experiments, artifactual data, and fun lab anecdotes.

Publish and Cherish Logo

 

Schedule 2022/2023

Date & Time Speaker

Title

12.07.2023 Madhuvanthi Kannan (University of Minnesota Medical School, USA)

Dual-polarity voltage imaging of the concurrent dynamics of multiple neuron types

12.04.2023 Ashutosh Dhingra (German Center for Neurodegenerative Diseases, Tübingen, Germany)

Drug screen in iPSC-Neurons identifies nucleoside analogs as inhibitors of (G4C2)n expression in C9orf72 ALS/FTD

15.02.2023 Melissa E. Murray (Department of Neuroscience, Mayo Clinic Jacksonville, USA)

Global neuropathologic severity of Alzheimer’s disease and locus coeruleus vulnerability influences plasma phosphorylated tau levels

15.01.2023 George Chao (Department of Genetics, Harvard University, USA)

helixCAM: A platform for programmable cellular assembly in bacteria and human cells

16.11.2022 Sofia Lovestam (MRC Laboratory of Molecular Biology, Cambridge, UK)

Assembly of recombinant tau into filaments identical to those of Alzheimer's disease and chronic traumatic encephalopathy

26.10.2022 Giovanni Pascarella (RIKEN, Japan) Recombination of repeat elements generates somatic complexity in human genomes
21.09.2022 Anne-Laure Mahul-Mellier (EPFL, CH) The process of Lewy body formation rather than simply alpha-synuclein fibrilization, is one of the major drivers of neurodegeneration

24.08.2022

16:00 EST

Bryan Copits (Washington University of Medicine in St. Lewis, USA) A photoswitchable GPCR-based opsin for presynapting inhibition

 

Schedule 2020/2021

Date & Time Speaker Title

26.05.2021

16:30 CEST

Marco Jost (University of California, San Francisco, San Francisco, CA, USA) Titrating gene expression using libraries of systematically attenuated CRISPR guide RNAs

12.05.2021

17:00 CEST

Jimena Andersen (Stanford University, Stanford, CA, USA) Generation of Functional Human 3D Cortico-Motor Assembloids

26.04.2021

16:30 CEST

Andrew Yang (Stanford University School of Medicine, Stanford, CA, USA) Physiological blood–brain transport is impaired with age by a shift in transcytosis
17.03.2021 16:00 CET Emanuela Pasciuto (VIB-KU Leuven) Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition  
03.03.2021 16:00 CET Zeynep H. Gümüş (Icahn School of Medicine at Mount Sinai) Interactive, visual exploration of massive -omics datasets
17.02.2021 16:00 CET Elvira Mass and Frederic Geissmann (Memorial Sloan Kettering Cancer Center / University of Bonn) A somatic mutation in erythro-myeloid progenitors causes neurodegenerative disease
03.02.2021 15:00 CET Francesco Simone Ruggeri (Wageningen University / University of Cambridge) The Influence of Pathogenic Mutations in α-Synuclein on Biophysical and Structural Characteristics of Amyloid Fibrils
08.12.2020 16:00 CET Kalil Alves de Lima Meningeal γδ T cells regulate anxiety-like behavior via IL-17a signaling in neurons

25.11.2020

16:00 CET

Leah Houri-Zeevi Three Rules Explain Transgenerational Small RNA Inheritance in C. elegans

10.11.2020

16:00 CET

Ting Zhou IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy

30.10.2020

16:00 CET

Elisabetta Babetto A glycolytic shift in Schwann cells supports injured axons

20.10.2020 14:00 CET

Ruslan Rust Nogo-A targeted therapy promotes vascular repair and functional recovery following stroke